Cytokinetics Stock Price Prediction

CYTK Stock  USD 50.25  1.15  2.34%   
The RSI of Cytokinetics' the stock price is about 67 suggesting that the stock is rather overbought by investors as of now. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Cytokinetics, making its price go up or down.

Oversold Vs Overbought

67

 
Oversold
 
Overbought
The successful prediction of Cytokinetics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Cytokinetics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Cytokinetics' stock price prediction:
EPS Estimate Next Quarter
(1.25)
EPS Estimate Current Year
(5.27)
EPS Estimate Next Year
(5.19)
Wall Street Target Price
81.4118
Quarterly Revenue Growth
0.225
Using Cytokinetics hype-based prediction, you can estimate the value of Cytokinetics from the perspective of Cytokinetics response to recently generated media hype and the effects of current headlines on its competitors.

Cytokinetics Hype to Price Pattern

Investor biases related to Cytokinetics' public news can be used to forecast risks associated with an investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cytokinetics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cytokinetics.
The fear of missing out, i.e., FOMO, can cause potential investors in Cytokinetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cytokinetics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cytokinetics after-hype prediction price

    
  USD 50.47  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Cytokinetics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
45.2357.0159.56
Details
Naive
Forecast
LowNextHigh
43.9946.5449.09
Details
19 Analysts
Consensus
LowTargetHigh
56.6762.2769.12
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.37-1.32-1.14
Details

Cytokinetics After-Hype Price Prediction Density Analysis

As far as predicting the price of Cytokinetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytokinetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cytokinetics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Cytokinetics Estimiated After-Hype Price Volatility

In the context of predicting Cytokinetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytokinetics' historical news coverage. Cytokinetics' after-hype downside and upside margins for the prediction period are 47.92 and 53.02, respectively. We have considered Cytokinetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
50.25
50.47
After-hype Price
53.02
Upside
Cytokinetics is very steady at this time. Analysis and calculation of next after-hype price of Cytokinetics is based on 3 months time horizon.

Cytokinetics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Cytokinetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytokinetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytokinetics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.13 
2.55
  0.22 
 0.00  
12 Events / Month
5 Events / Month
In about 12 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
50.25
50.47
0.44 
152.69  
Notes

Cytokinetics Hype Timeline

Cytokinetics is currently traded for 50.25. The entity has historical hype elasticity of 0.22, and average elasticity to hype of competition of 0.0. Cytokinetics is anticipated to increase in value after the next headline, with the price projected to jump to 50.47 or above. The average volatility of media hype impact on the company the price is about 152.69%. The price upswing on the next news is projected to be 0.44%, whereas the daily expected return is currently at -0.13%. The volatility of related hype on Cytokinetics is about 38250.0%, with the expected price after the next announcement by competition of 50.25. The company reported the previous year's revenue of 7.53 M. Net Loss for the year was (526.24 M) with loss before overhead, payroll, taxes, and interest of (146.22 M). Given the investment horizon of 90 days the next anticipated press release will be in about 12 days.
Check out Cytokinetics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.

Cytokinetics Related Hype Analysis

Having access to credible news sources related to Cytokinetics' direct competition is more important than ever and may enhance your ability to predict Cytokinetics' future price movements. Getting to know how Cytokinetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytokinetics may potentially react to the hype associated with one of its peers.

Cytokinetics Additional Predictive Modules

Most predictive techniques to examine Cytokinetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics using various technical indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cytokinetics Predictive Indicators

The successful prediction of Cytokinetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytokinetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytokinetics based on analysis of Cytokinetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytokinetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytokinetics's related companies.
 2021 2022 2023 2024 (projected)
Graham Number15.011.0122.1621.05
Receivables Turnover1.36643.465.875.58

Story Coverage note for Cytokinetics

The number of cover stories for Cytokinetics depends on current market conditions and Cytokinetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytokinetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytokinetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cytokinetics Short Properties

Cytokinetics' future price predictability will typically decrease when Cytokinetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytokinetics often depends not only on the future outlook of the potential Cytokinetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytokinetics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding96.5 M
Cash And Short Term Investments614.8 M
When determining whether Cytokinetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cytokinetics Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cytokinetics Stock. Highlighted below are key reports to facilitate an investment decision about Cytokinetics Stock:
Check out Cytokinetics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.38)
Revenue Per Share
0.03
Quarterly Revenue Growth
0.225
Return On Assets
(0.30)
Return On Equity
(5.72)
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.